CHIMICA E FARMACEUTICA

SHENZHEN, China, Sept. 25, 2023 /PRNewswire/ -- The China International Medical Equipment Fair (CMEF), organized by Reed Sinopharm Exhibitions, serves as an excellent bridge for brands aiming to enter the Chinese market. The 88th edition of this prestigious medical event is scheduled to take place from October 28 to 31 at the Shenzhen World Exhibition & Convention Center. These exhibitors will showcase cutting-edge products and solutions to meet the significant demands in the Chinese market.

Milano, 22 settembre 2023 - BMG Pharma, azienda italiana leader nel settore biotecnologico, annuncia importanti sviluppi e iniziative che testimoniano il suo impegno per l'innovazione, la ricerca scientifica e il miglioramento del benessere umano.

SEUL, Corea del Sud, 13 settembre 2023 /PRNewswire/ -- Seegene Inc. (KQ096530), azienda leader nella Corea del Sud che fornisce una soluzione totale per la diagnostica molecolare PCR, ha presentato oggi il suo "Open Innovation Program powered by Seegene (Open Innovation Program)" in collaborazione con Springer Nature, uno dei principali fornitori di servizi alla comunità di ricerca. Il programma inaugurale è disponibile a livello globale e rappresenta il primo passo per consentire a esperti, scie...

AMSTERDAM, Sept. 11, 2023 /PRNewswire/ -- Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment of Saulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience and a unique blend of leadership, operational expertise, and a deep understanding of manufacturing operational excellence and supply chain.

HOUSTON and LONDON, Sept. 7, 2023 /PRNewswire/ -- LyondellBasell today announced it has been named as one of the Best Companies to Work For in the U.S. News & World Report2023-2024 rankings. LyondellBasell was compared to 200 companies and was evaluated based on how well the company met expectations important to job seekers in finding a workplace that aligns with their needs.

CORK, Ireland and PHILADELPHIA, Sept. 6, 2023 /PRNewswire/ -- CXV Global and Panacea Technologies today announced their new name, Catalyx, to reflect their united purpose and offering focused on optimizing operations for organizations in life sciences and other highly regulated industries.

HOUSTON e LONDRA, 6 settembre 2023 /PRNewswire/ -- LyondellBasell (NYSE: LYB) ospiterà un webinar sulla tecnologia MoReTec martedì 26 settembre dalle 8:00 alle 9:00. CDT. Jim Seward, vicepresidente esecutivo e direttore dell'innovazione, e Yvonne van der Laan, vicepresidente esecutivo per le soluzioni circolari e a basse emissioni di carbonio, condivideranno i fattori di business e il background tecnologico che hanno portato allo sviluppo della tecnologia di riciclaggio avanzata di proprietà di L...

JOINVILLE, Brazil, Aug. 24, 2023 /PRNewswire/ -- The Vittra APS Unique composite, by FGM Dental Group, was recognized for its chameleon effect in the publication Clinical Problem Solvers of the renowned American agency Dental Advisor - a global reference in the field of dentistry. In the publication, consultants analyze products which offer solutions to clinical problems.

KYOTO, Japan, Aug. 24, 2023 /PRNewswire/ -- OMRON Healthcare Co., Ltd. (hereinafter referred to as the Company) based in Muko, Kyoto Prefecture, has announced the official sponsorship of European Society of Cardiology Congress 2023 (hereinafter referred to as ESC Congress 2023) via OMRON Healthcare Europe B.V., OMRON Healthcare's sales and marketing headquarters in Europe. The annual ESC congress, the world's largest congress on cardiovascular diseases, will be held from August 25 to 28, 2023, at...

PROVIDENCE, R.I., Aug. 11, 2023 /PRNewswire/ -- EpiVax Inc. announces the publication of results from a research collaboration with the Food and Drug Administration aimed at streamlining generic drug evaluations. The research, initiated in 2018 with a $1M contract spanning two years (HHSF223018186C), was established to develop best practices for assessing the immunogenic potential of active pharmaceutical ingredients and their impurities for filing Abbreviated New Drug Applications (ANDAs). Addit...

La società si prepara a introdurre il dispositivo indossabile soggetto a prescrizione medica in Europa l'anno prossimo 

MUMBAI, India, 4 agosto 2023 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), ha annunciato oggi i suoi risultati consolidati per il primo trimestre Q1 (terminato il 30 giugno 2023).

TOKYO, Aug. 3, 2023 /PRNewswire/ -- Polyplastics Group, a leading global supplier of engineering thermoplastics, has launched the DURACIRCLE (TM) initiative for recycling engineering plastics. This effort applies to a wide variety of sustainable solutions that contribute toward achieving a 100% recycling rate for engineering plastics, without being confined to the existing business model of manufacturing and selling plastics. Polyplastics' goal is to achieve carbon neutrality by 2050.

SAN LUIS OBISPO, Calif., July 27, 2023 /PRNewswire/ -- This planned purchase, which will ship to Senic in Q4-2023, reinforces the 6EZ's position as the most flexible chemical mechanical polishing (CMP) platform available to support silicon carbide (SiC) substrate manufacturing and the fabrication of devices such as SiC-based MOSFET's.

New system enhances real-time customer insights, launch planning, and engagement for new therapies

Il commento delle aziende degli off patent alla seconda seduta del tavolo farmaci al MIMIT. Plauso ai ministri Schillaci e Urso

HOUSTON e ROTTERDAM, Paesi Bassi, 20 luglio 2023 /PRNewswire/ -- LyondellBasell (NYSE: LYB) ha annunciato in data odierna di aver ottenuto un rating di AA in base alla scala di valutazione MSCI ESG, che va da CCC ad AAA, ed è pertanto inclusa ora nella categoria dei "leader". Il nuovo rating costituisce un miglioramento rispetto allo status di "A" conferito a LyondellBasell l'anno scorso, ove tale salto di livello è riconducibile alle iniziative intraprese dall'azienda ai fini della mitigazione d...